Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the stock exchanges about a scheduled investor/analyst meeting. On August 6, 2025, company representatives will meet with Nine River Capital in a one-on-one, in-person format in Mumbai. The disclosure is filed under SEBI's Listing Obligations and Disclosure Requirements Regulations. The company notes that the schedule and mode may change due to unforeseen circumstances.
This is a routine regulatory disclosure with no direct material impact on shareholders or the stock price. Investors may monitor the meeting for any strategic insights shared by the company with Nine River Capital.